What is ReWalk Robotics's market cap?

ReWalk Robotics (LFWD) has a market capitalization of $20.8M and trades on NASDAQ.

Who are ReWalk Robotics's competitors?

ReWalk Robotics's key competitors include Bioventus, Myomo Inc., Enovis Corporation, and others. These companies compete in similar markets and product categories.

Who does ReWalk Robotics partner with?

ReWalk Robotics's notable partners include MYOLYN, CorLife, Numotion, and others.

What subsidiaries does ReWalk Robotics have?

ReWalk Robotics's subsidiaries include AlterG, Inc., Oratech Pharma, Inc..

Where is ReWalk Robotics headquartered?

ReWalk Robotics is headquartered in Israel and employs approximately 108 people. It has been publicly traded since 2014.

ReWalk Robotics (LFWD) Stock Fundamentals & Financials

Lifeward is a medical device company specializing in the design, development, and commercialization of robotic rehabilitation and recovery solutions.

Market cap

$20.83M+86.2%

Earnings

Q1 2026 report

May 15, 2026

Revenue$3.9MMiss by $1.9M EPS-$6.70Miss by $5.52

Read the full report

Next report

Aug 14, 2026 (In 5 days)

Revenue estimate$6.5M

EPS estimate-$1.39

Competitors

By market cap

Enovis$1.5B+3.1%

Bioventus$1.2B+143%

AdaptHealth$806.5M-39.5%

OrthoPediatrics$596.1M+32.8%

Viemed Healthcare, Inc.$362.6M+42.2%

Myomo$51.9M-22.0%

ReWalk Robotics$20.8M+91.0%

Nexalin Technology, Inc.$7.5M-56.2%

By revenue growth

Viemed Healthcare, Inc.+23.1%

OrthoPediatrics+14.5%

Enovis+4.9%

Bioventus+3.1%

AdaptHealth+1.2%

By net margin

Bioventus9.36%+9.5pp

Viemed Healthcare, Inc.5.2%-0.1pp

AdaptHealth-2.42%-5.0pp

OrthoPediatrics-15.72%+3.2pp

Enovis-47.97%-10.2pp

Profile

Lifeward is a medical device company specializing in the design, development, and commercialization of robotic rehabilitation and recovery solutions. The company provides advanced technologies, including exoskeletons and anti-gravity systems, that deliver functional and health benefits to individuals with physical disabilities. Its core value proposition centers on enabling mobility and improving clinical outcomes for patients in both professional healthcare settings and home environments.

Competitive position

Lifeward is a pioneer in the medical exoskeleton market, holding the first FDA clearance for stair and curb functionality and maintaining a significant global installed base of anti-gravity systems.

GeographiesUnited States, Germany, Europe, Asia-Pacific, Middle East

Customer segmentsHealthcare providers, Government health agencies, Professional sports organizations, Individual patients

Business modelDirect-to-consumer sales, B2B equipment sales, Distributor-led sales, Service and maintenance contracts

SuppliersElectronic component suppliers, Contract manufacturers, NASA-derived technology licenses, Academic research institutions

CustomersRehabilitation hospitals, Physical therapy clinics, Veterans Health Administration, Private health insurers, Workers' compensation payors

CountryIsrael

Listed2014

Employees108.0

CEOWilliam Mark Grant

SectorHealthcare

IndustryMedical - Devices

Websiterewalk.com

FilingsSEC EDGAR

FAQ

What is ReWalk Robotics's market cap?: ReWalk Robotics (LFWD) has a market capitalization of $20.8M and trades on NASDAQ.
Who are ReWalk Robotics's competitors?: ReWalk Robotics's key competitors include Bioventus, Myomo Inc., Enovis Corporation, and others. These companies compete in similar markets and product categories.
Who does ReWalk Robotics partner with?: ReWalk Robotics's notable partners include MYOLYN, CorLife, Numotion, and others.
What subsidiaries does ReWalk Robotics have?: ReWalk Robotics's subsidiaries include AlterG, Inc., Oratech Pharma, Inc..
Where is ReWalk Robotics headquartered?: ReWalk Robotics is headquartered in Israel and employs approximately 108 people. It has been publicly traded since 2014.